BrightWhistle Inc., a first-in-class social patient acquisition platform provider, has raised $2.05 million in Series A funding, led by Huntsville based Eastside Partners, Atlanta-based Hamilton Ventures, Atlanta angel investor Paul Iaffaldano and prominent healthcare technology focused angel investors Fred Goad and G.T. Laborde.
The company also landed several new clients including Piedmont Healthcare, Duke Raleigh Hospital and Dekalb Medical.
BrightWhistle presented at TechMedia’s 5th annual Southeast Venture Conference in 2011. The TechJournal is a TechMedia company.
The only HIPAA-compliant, healthcare-focused Facebook Ads API partner, the company will use the funding to advance the continued development of its comprehensive solution designed to empower hospitals’ efforts to engage and acquire new patients through search and social media.
“We are thrilled to have all of our investors back in this round, along with the addition of two healthcare industry veterans, Fred Goad and G.T. Laborde,” said BrightWhistle co-founder and CEO Greg Foster.
“We have spent the last year building a world class solution, establishing strong client relationships with some of the leading hospitals in the US, and building powerful case studies that demonstrate our solution’s capacity to significantly increase return on health care marketing budgets.”
“The fact that we were able to raise more than twice the amount of capital than we originally intended is a testament to what we are building,” said Chad Mallory, co-founder and COO, BrightWhistle
“A continual development cycle keeps our platform delivering optimal results for our clients, and having additional resources to invest enables us to accelerate our product roadmap.”
“BrightWhistle is first-to-market with a solution designed to empower the health care marketer’s social and digital media strategy. Everyone in the industry is capable of benefitting from its implementation – health care providers seeking to engage and acquire new patients, payers seeking to add customers, and other institutions focused on meeting Stage 1 and 2 Meaningful Use objectives,” said Emerson Fann, Managing Partner of Eastside Partners.
“We are excited to increase our investment in a venture that is fundamentally changing the methods employed by healthcare marketers across the country and around the world.”